within Pharmacolibrary.Drugs.ATC.D;

model D03AX06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Becaplermin is a recombinant human platelet-derived growth factor (PDGF-BB) indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have adequate blood supply. It is formulated as a topical gel and is approved for clinical use.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic human study data are available for becaplermin. As a topical agent, systemic absorption is expected to be minimal. Published literature and regulatory documents indicate negligible systemic exposure after dermal application, with most of the drug remaining localized at the site of application.</p><h4>References</h4><ol><li><p>Balfour, JA, &amp; Noble, S (1999). Becaplermin. <i>BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</i> 11(5) 359–364. DOI:<a href=&quot;https://doi.org/10.2165/00063030-199911050-00007&quot;>10.2165/00063030-199911050-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18031145/&quot;>https://pubmed.ncbi.nlm.nih.gov/18031145</a></p></li><li><p>Senet, P (2004). [Becaplermin gel (Regranex gel)]. <i>Annales de dermatologie et de venereologie</i> 131(4) 351–358. DOI:<a href=&quot;https://doi.org/10.1016/s0151-9638(04)93614-9&quot;>10.1016/s0151-9638(04)93614-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15258509/&quot;>https://pubmed.ncbi.nlm.nih.gov/15258509</a></p></li><li><p>Li, H, et al., &amp; Sun, T (2008). Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics. <i>The Journal of surgical research</i> 145(1) 41–48. DOI:<a href=&quot;https://doi.org/10.1016/j.jss.2007.02.044&quot;>10.1016/j.jss.2007.02.044</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18082770/&quot;>https://pubmed.ncbi.nlm.nih.gov/18082770</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D03AX06;
